ArticleClinical, cosmetic and investigational dermatology2026
Successful Treatment of Refractory Pemphigus Vulgaris with Ultra-Low-Dose Rituximab in a High-Risk Patient: A Case Report.
Hui Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.